Biological Samples Sample Clauses
The 'Biological Samples' clause defines the terms and conditions under which biological materials, such as tissues, blood, or other specimens, are collected, used, stored, and possibly transferred between parties. It typically outlines the permitted uses of the samples, requirements for handling and storage, and any restrictions on sharing or commercializing the materials. This clause ensures that all parties understand their rights and obligations regarding the samples, thereby protecting the integrity of the research and addressing ethical, legal, and ownership concerns.
POPULAR SAMPLE Copied 7 times
Biological Samples. “Biological Samples” means blood, fluid and/or tissue samples collected from Trial Subjects as may be set forth in the Protocol, and tangible materials directly or indirectly derived from such samples. Institution and Investigator will collect, retain and/or use Biological Samples solely as set forth in the Protocol. Institution and/or Investigator will provide Sponsor with quantities of Biological Samples as required by the Protocol. Sponsor may use such Biological Samples as specified in the Protocol, and as permitted in the Consent Documents and by Applicable Law. 8.3
Biological Samples. If so specified in the Protocol and the informed consent document, Principal Investigator may collect and provide to CRO, Pfizer or their designee biological samples obtained from Study Subjects (e.g., blood, urine, tissue, saliva, etc) for testing that is not directly related to Study Subject care or safety monitoring, such as pharmacokinetic, pharmacogenomic, or biomarker testing (“Biological Samples”). Biological Samples may include Personal Data of Study Subjects. 11.2
Biological Samples. 2.9.1 Institution/Principal Investigator shall use all samples derived from Study subjects enrolled in the Study, including blood, bone marrow, sera, platelets and other biological materials in accordance with the Protocol and the Study subject informed consent.
Biological Samples. If so specified in the Protocol, Institution and Principal Investigator may collect and provide to Sponsor or its designee Biological Samples (“Biological Samples”).
Biological Samples. If so specified in the Protocol, Institution and Principal Investigator may collect and provide to Sponsor or its designee biological samples (e.g., blood, urine, tissue, saliva, etc.) obtained from Trial Subjects for testing that is not directly related to patient care or safety monitoring, including pharmacokinetic, pharmacogenomic, or biomarker testing (“Biological Samples”).
Biological Samples. If so specified in the Protocol, Institution may collect and provide to Sponsor or its designee biological samples (e.g., blood, urine, tissue, saliva, etc.) obtained from Trial Subjects for testing that is not directly related to patient care or safety monitoring, including pharmacokinetic, pharmacogenomic, or biomarker testing (“Biological Samples”). 11.2 Vzorky biologického materiálu. Pokiaľ je uvedené v protokole inštitúcia môže zhromaždiť a odovzdať zadávateľovi alebo ním poverenému zástupcovi vzorky biologického materiálu (napr. vzorky krvi, moču, tkanív, slín atď.) odobraté subjektom skúšania na účely testovania, ktoré nesúvisí priamo so starostlivosťou o pacienta alebo bezpečnostným monitorovaním vrátane testovania farmakokinetických a farmakogenomických vlastností a biomarkerov (ďalej len „vzorky biologického materiálu“).
Biological Samples. If so specified in the Protocol, Institution and Principal Investigator may collect and provide to Sponsor or its designee blood, fluid and/or tissue samples collected from Trial Subjects (“Biological Samples”). All Biological Samples shall be the sole property of Sponsor.
Biological Samples. It is expected that the Institution will, from time to time, transfer Biological Samples to the Sponsor. The Parties agree that any such transfer of Biological Samples shall be subject to the following terms and conditions.
Biological Samples. If so specified in the Protocol and the informed consent document, Principal Investigator may collect and provide to CRO, Sponsor or their designee, biological samples obtained from trial subjects (e.g., blood, urine, tissue, saliva, etc) for testing that is not directly related to trial subject care or safety monitoring, such as pharmacokinetic, pharmacogenomic, or biomarker testing (“Biological Samples”). Biological Samples may include Personal Data (as defined elsewhere herein) of trial subjects of which the processing is governed by the applicable legislation in the territory of the Slovak Republic. For the avoidance of doubt, the Contracting Parties explicitly confirm, that the restriction of processing Personal Data of trial subjects exclusively in pseudonymized form, as indicated in Appendix 2, Art. 10.5, shall apply in full extent also to Biological Samples of trial subjects. a.
Biological Samples. If so specified in the Protocol and the informed consent document, Principal Investigator may collect and provide to CRO, Sponsor or their designee, biological samples obtained from trial subjects (e.g., blood, urine, tissue, saliva, etc.) for testing that is not directly related to trial subject care or safety monitoring, such as pharmacokinetic, pharmacogenomic, or biomarker testing (“Biological Samples”). Biological Samples may include Personal Data (as defined below) of trial subjects. 2.37 Biologické vzorky. V súlade s protokolom a s dokumentom informovaného súhlasu môže zodpovedný skúšajúci odoberať u účastníkov klinického skúšania a poskytovať zmluvnej výskumnej organizácii, zadávateľovi alebo nimi poverenej osobe biologické vzorky (napr. krv, moč, tkanivo, sliny atď.) ▇▇▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ na testovanie, ktoré priamo nesúvisí so starostlivosťou o účastníkov klinického skúšania alebo so sledovaním bezpečnosti, ako sú farmakokinetické, farmakogenomické testovania alebo testovanie zamerané na biomarkery (ďalej len „biologické vzorky“). K biologickým vzorkám môžu patriť osobné údaje (ako je nižšie definované) účastníkov klinického skúšania.